Navidea (NAVB) Schedules Meeting w/ FDA in Mid-October for Lymphoseek

September 24, 2012 2:51 PM

On September 10, 2012, Navidea Biopharma (AMEX: NAVB) announced that it had received a complete response letter (CRL) from the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found